GlassScriptPhysician profile
Saadiq El-Amin
NPI 1972718328
$5,170.94
in general payments reported to CMS, 2019-2025
27 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $1,225 · 2021: $1,214 · 2022: $1,036 · 2023: $771 · 2024: $470 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,061 · Travel and Lodging: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,060.58 |
| Travel and Lodging | $417.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,531.62 | 2021-2023 | Caliber, Altera |
| Medacta USA, INC. | $1,019.50 | 2020 | |
| Medical Device Business Services, INC. | $922.78 | 2019-2021 | |
| Smith+Nephew, INC. | $593.78 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Biosure, Bone Anchors With Arthroscopic Delivery System |
| Depuy Synthes Sales INC. | $440.67 | 2020-2022 | |
| Endo USA, INC. | $112.91 | 2025 | |
| Horizon Therapeutics Plc | $65.63 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $46.38 | 2021 | |
| Pfizer INC. | $43.00 | 2023 | |
| Bioventus LLC | $41.20 | 2024 | Exogen Ultrasound Bone Healing System |
| Sanofi-Aventis U.S. LLC | $40.37 | 2023 | |
| Organogenesis INC. | $35.99 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $33.52 | 2025 | |
| Moximed, INC | $29.44 | 2025 | Misha Knee System, Small, Left |
| Electronic Waveform Lab, INC. | $26.73 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $25.18 | 2023 | Xaracoll |
| Anika Therapeutics, INC. | $19.49 | 2024 | Integrity, Ovomotion |
| Pacira Pharmaceuticals Incorporated | $17.90 | 2025 | Zilretta |
| Treace Medical Concepts, INC. | $17.90 | 2023 | |
| Ermi LLC | $17.89 | 2024 | |
| Abbott Laboratories | $17.64 | 2024 | Proclaim |
| Sonex Health, INC. | $16.32 | 2022 | |
| Mimedx Group, INC. | $16.07 | 2025 | |
| Zimvie INC. | $14.24 | 2022 | |
| Ibsa Pharma INC. | $12.80 | 2023 | Tirosint, Licart |
| Ethicon US, LLC | $11.99 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saadiq El-Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.